|
Market Closed -
Xetra
18:35:32 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 21.81 EUR | -1.31% |
|
+5.67% | +3.66% |
| 09-18 | European Equities Traded in the US as American Depositary Receipts Drop in Friday Trading | MT |
| 09-18 | GSK plc : Deutsche Bank remains Neutral | ZD |
Company Valuation: GSK plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,458 | 58,381 | 59,112 | 54,944 | 73,201 | 75,232 | - | - |
| Change | - | -27.44% | 1.25% | -7.05% | 33.23% | 2.77% | - | - |
| Enterprise Value (EV) 1 | 100,296 | 75,578 | 74,152 | 68,039 | 87,654 | 95,913 | 93,199 | 90,323 |
| Change | - | -24.65% | -1.89% | -8.24% | 28.83% | 9.42% | -2.83% | -3.09% |
| P/E | 18.6x | 3.93x | 11.9x | 21.3x | 12.9x | 14.4x | 12x | 11x |
| PBR | 5.34x | 5.47x | 4.4x | 4.02x | 4.51x | 4.59x | 4.03x | 3.55x |
| PEG | - | 0x | -0.2x | -0.4x | 0x | -1.89x | 0.6x | 1.24x |
| Capitalization / Revenue | 2.36x | 1.99x | 1.95x | 1.75x | 2.24x | 2.22x | 2.12x | 2.06x |
| EV / Revenue | 2.94x | 2.58x | 2.45x | 2.17x | 2.68x | 2.83x | 2.63x | 2.47x |
| EV / EBITDA | 8.85x | 7.23x | 6.37x | 6.36x | 7.77x | 8.36x | 7.6x | 7.11x |
| EV / EBIT | 11.4x | 9.27x | 8.44x | 7.44x | 8.96x | 9.3x | 8.44x | 7.83x |
| EV / FCF | 22.6x | 12.1x | 13.6x | 13x | 13.7x | 17.3x | 16.1x | 13.3x |
| FCF Yield | 4.42% | 8.28% | 7.36% | 7.67% | 7.32% | 5.79% | 6.21% | 7.53% |
| Dividend per Share 2 | 1 | 0.6125 | 0.58 | 0.61 | 0.66 | 0.6958 | 0.7494 | 0.7843 |
| Rate of return | 4.98% | 4.26% | 4% | 4.53% | 3.62% | 3.71% | 3.99% | 4.18% |
| EPS 2 | 1.082 | 3.662 | 1.216 | 0.632 | 1.411 | 1.303 | 1.571 | 1.71 |
| Distribution rate | 92.4% | 16.7% | 47.7% | 96.5% | 46.8% | 53.4% | 47.7% | 45.9% |
| Net sales 1 | 34,114 | 29,324 | 30,328 | 31,376 | 32,667 | 33,934 | 35,504 | 36,608 |
| EBITDA 1 | 11,330 | 10,449 | 11,635 | 10,693 | 11,278 | 11,466 | 12,264 | 12,707 |
| EBIT 1 | 8,806 | 8,151 | 8,786 | 9,148 | 9,783 | 10,310 | 11,046 | 11,531 |
| Net income 1 | 4,385 | 14,956 | 4,928 | 2,575 | 5,716 | 5,348 | 6,284 | 6,856 |
| Net Debt 1 | 19,838 | 17,197 | 15,040 | 13,095 | 14,453 | 20,681 | 17,968 | 15,091 |
| Reference price 2 | 20.08 | 14.38 | 14.50 | 13.46 | 18.24 | 18.78 | 18.78 | 18.78 |
| Nbr of stocks (in thousands) | 4,006,383 | 4,060,999 | 4,076,145 | 4,080,519 | 4,012,126 | 4,007,011 | - | - |
| Announcement Date | 2/9/22 A | 2/1/23 A | 1/31/24 A | 2/5/25 A | 2/4/26 A | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 32.78x | 11.92x | 24.16x | 0.6% | 1,028B | |
| 30.03x | 6.68x | 18.7x | 1.99% | 651B | |
| 33.38x | 7.81x | 16.15x | 2.6% | 466B | |
| 19.33x | 4.72x | 11.71x | 2.81% | 346B | |
| 19.72x | 5.16x | 12.79x | 3.11% | 266B | |
| 21.26x | 4.42x | 12.58x | 1.99% | 259B | |
| 24.43x | 6.42x | 11.43x | 2.62% | 208B | |
| 12.52x | 4.56x | 9.46x | 4.01% | 191B | |
| -45.4x | 6.61x | 25.81x | 2.19% | 186B | |
| Average | 16.45x | 6.48x | 15.87x | 2.44% | 400.19B | |
| Weighted average by Cap. | 23.68x | 7.73x | 17.83x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
- Valuation GSK plc
Select your edition
All financial news and data tailored to specific country editions
